期刊文献+

妊娠糖尿病患者血清miR-330-3p、lncRNA SNHG17表达水平及临床意义

The expression level and their clinical significance of miR-330-3p and lncRNA SNHG17 in the serun of patients with gestational diabetes mellitus
原文传递
导出
摘要 目的 探究妊娠糖尿病(GDM)患者血清miR-330-3p、长链非编码RNA(lncRNA)小核仁RNA宿主基因17(SNHG17)表达水平及对不良妊娠结局的预测价值。方法 招募2021年1月至2022年2月西北妇女儿童医院产科产检及分娩的160例GDM孕妇(GDM组)和160例糖耐量试验正常的健康孕妇(对照组)为研究对象。荧光定量PCR反应检测血清miR-330-3p、lncRNA SNHG17表达水平;Pearson法分析lncRNA SNHG17与miR-330-3p及二者与空腹血糖(FBG)等生化指标的相关性;多因素Logistic回归分析GDM孕妇妊娠结局的影响因素;受试者操作特征(ROC)曲线分析lncRNASNHG17、miR-330-3p对GDM孕妇不良妊娠结局的预测价值。结果 与对照组相比,GDM孕妇血清糖化血红蛋白(HbA1c)、空腹血糖(FBG)、OGTT后2 h血糖、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)、miR-330-3p水平较高(P<0.05),HOMA-β、lncRNA SNHG17较低(P<0.05)。GDM孕妇血清miR-330-3p、lncRNA SNHG17与FBG等生化指标密切相关(P<0.05)。GDM孕妇血清中miR-330-3p与lncRNA SNHG17呈负相关(P<0.05)。Logistic分析显示,在GDM孕妇中,miR-330-3p高水平、lncRNA SNHG17低水平为不良妊娠结局的危险因素(P<0.05)。ROC结果显示,miR-330-3p、lncRNA SNHG17联合对GDM孕妇妊娠结局的预测价值显著优于单独指标(P<0.05)。结论 GDM孕妇血清miR-330-3p水平较高,lncRNA SNHG17较低,二者联合对GDM孕妇不良妊娠结局的预测价值优于单一指标。 Objective To investigate the expression levels of serum miR-330-3p and long non-coding RNA(lncRNA)small nucleolar RNA host gene 17(SNHG17) and the predictive value of adverse pregnancy outcomes in gestational diabetes mellitus(GDM) patients. Methods From January 2021 to February 2022, 160 pregnant women with GDM(GDM group) and 160 healthy pregnant women with normal glucose tolerance(control group) in the Department of Obstetrics and Gynecology,Northwest Women’s and Children’s Hospital were recruited for the study. The expression levels of miR-330-3p and lncRNA SNHG17 in serum were measured by fluorescence quantitative PCR reaction. Pearson correlation analysis of lncRNA SNHG17and miR-330-3p and the correlation between the two and their biochemical indexes such as fasting blood glucose(FBG). Multivariate Logistic regression was used to analyze the influencing factors of pregnancy outcomes in pregnant women with GDM.Receiver operating(ROC) curve was used to analyze the predictive value of lncRNA SNHG17 and miR-330-3p on adverse pregnancy outcomes in pregnant women with GDM. Results Compared with the control group, the levels of serum glycated haemoglobin A1C(HbA1c), fasting blood glucose(FBG), 2 h blood glucose after OGTT, fasting insulin(FINS), homeostasis model assessment of insulin resistance(HOMA-IR) and miR-330-3p were higher in GDM pregnant women(P<0.05), while HOMA-β and lncRNA SNHG17 were lower(P<0.05). Serum miR-330-3p and lncRNA SNHG17 were strongly correlated with biochemical indicators such as FBG in pregnant women with GDM(P<0.05).(P<0.05). Serum miR-330-3p was negatively correlated with lncRNA SNHG17 in pregnant women with GDM(P<0.05). Logistic analysis showed that high level of miR-330-3p and low level of lncRNA SNHG17 were risk factors of adverse pregnancy outcomes in pregnant women with GDM(P<0.05). The ROC results showed that the combined predictive value of miR-330-3p and lncRNA SNHG17 on pregnancy outcome in pregnant women with GDM was significantly better than that of the indicators alone(P<0.05). Conclusion The serum level of miR-330-3p in pregnant women with GDM is elevated, while the level of lncRNA SNHG17 is decreased. The predictive value of the combined two is better than the single indicator for adverse pregnancy outcomes in pregnant women with GDM.
作者 康瑛 王小凤 贺同强 KANG Ying;WANG Xiaofeng;HE Tongqiang(Department of Obstetrics and Gynecology,Northwest Women's and Children's Hospital,Xi'an,Shaanxi 710061,China)
出处 《中国优生与遗传杂志》 2022年第12期2210-2214,共5页 Chinese Journal of Birth Health & Heredity
基金 陕西省重点研发计划项目(2018SF-078)。
关键词 妊娠糖尿病 miR-330-3p 长链非编码RNA 小核仁RNA宿主基因17 妊娠结局 gestational diabetes mellitus miR-330-3p long non-coding RNA small nucleolar RNA host gene 17 pregnancy outcome
  • 相关文献

二级参考文献54

  • 1Kahn CR.Joslin糖尿病学[M].14版.潘长玉,主译.北京:人民卫生出版社,2005:550-552.
  • 2中华医学会妇产科学分会产科学组,中华医学会围产医学分会妊娠合并糖尿病协作组.妊娠合并糖尿病临床诊断与治疗推荐指南(草案)[J].中华妇产科杂志,2007,42:426-428.
  • 3中华人民共和国国家卫生部.WS331-2011妊娠期糖尿病诊断[s]北京:中华人民共和国国家卫生部,2011.
  • 4International Association of Diabetes and Pregnancy 3tudy Groups Consensus Panel,Metzger BE,Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J].Diabetes Care,2010,33:676-682.
  • 5International Diabetes Federation. Global Guideline on Pregnancy and Diabetes[S].Brussels: International Diabetes Federation,2009.
  • 6Walker JD. Diabetes in pregnancy:management of diabetes and its complications from pre-conception to the postnatal period. NICE guideline 63. London, March 2008[J]. Diabet Med, 2008, 25: 1025-1027.
  • 7Hoffman L,Nolan C,Wilson JD,et al.Gestational diabetes mellitus-management guidellnes.The Australasian Diabetes in Pregnancy Society[J].Med J Aust, 1998,169:93-97.
  • 8Canadian Diabetes Association.2008 CDA clinical practiceguidelines for the prevention and management of diabetes in Canada[J].Can J Diabetes,2008,32:S168-180.
  • 9Hadar E,Oats J,Hod M.Towards new diagnostic criteria for diagnosing GDM:the HAPO study[J].J Perinat Med, 2009, 37: 447-449.
  • 10Crowther CA,Hiller JE,Moss JR,et al.Effeet of treatment of gestational diabetes mellitus on pregnancy outeomes[J].N Engl J Med,2005,352:2477-2486.

共引文献1403

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部